GRAIL, Inc. Capital Expenditures
GRAIL, Inc. (GRAL) reported Capital Expenditures of $935.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- GRAIL, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $432.00K, a 17.07% increase year-over-year.
- GRAIL, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $503.00K, a 711.29% increase year-over-year.
- GRAIL, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $94.00K, a 68.98% decline year-over-year.
- GRAIL, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $384.00K, a 60.45% decline year-over-year.
- GRAIL, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $909.00K, a 82.55% decline from fiscal 2024.
- GRAIL, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $5.21M, a 59.59% decline from fiscal 2023.
- GRAIL, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $12.89M, a 43.62% decline from fiscal 2023.
- GRAIL, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $22.86M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $432.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $935.00K 10-Q · filed 2026-08-06 | $1.03M derived: sum of 3 quarters · filed 2026-08-06 | $1.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $503.00K 10-Q · filed 2026-05-07 | $597.00K derived: sum of 2 quarters · filed 2026-05-07 | $981.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.35M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $478.00K derived: sum of 2 quarters · filed 2026-03-12 | $847.00K derived: sum of 3 quarters · filed 2026-08-06 | $909.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $753.00K derived: sum of 2 quarters · filed 2026-08-06 | $815.00K 10-Q · filed 2025-11-13 | $1.12M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $431.00K 10-Q · filed 2026-08-06 | $734.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $62.00K 10-Q · filed 2026-05-07 | $365.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.34M derived: sum of 3 quarters · filed 2026-05-07 | $2.72M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.27M derived: sum of 2 quarters · filed 2026-03-12 | $2.66M derived: sum of 3 quarters · filed 2026-03-12 | $5.21M 10-K · filed 2026-03-12 |
| 2024-09-30 | $971.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $2.36M derived: sum of 2 quarters · filed 2025-11-13 | $4.91M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $3.93M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $2.55M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | $12.89M 10-K · filed 2025-03-05 | |||
| 2023-01-01 | $22.86M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |